Stock & Company Details
Arcutis Biotherapeutics Inc $ARQT
Price:
N/A
N/A
126M
$3.1B
52 Week High:
N/A
10 Day Average Volume:
N/A
114.17
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ARQT technical indicators
Latest Arcutis Biotherapeutics Inc (ARQT) indicator readings as of 2026-10-09.
ARQT's 14-day RSI is 56.2, in neutral territory. At $26.58 it is trading 5.8% above its 200-day moving average of $25.11, and above its 50-day average of $25.39. Price sits in the middle of its Bollinger Bands ($23.39 to $28.05). ADX reads 18.4, indicating a range-bound market rather than a trend.
Overview
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
Finance Bot
Ask your questions
Start by typing a question below.
